OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

Schweizerische Nationalbank/  CH0001319265  /

Nasdaq Other OTC
9/17/2024  3:30:02 PM Chg. - Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
4,187.5500USD - 1
Turnover: 4,187.5500		 -Bid Size: - -Ask Size: - 421.82 mill.USD - -
TeleTrader 3/1 SNB Chairman Jordan to step down in Sept. 2024
GlobeNewswire 1/5/2022 Pactiv Evergreen to Sell its Carton Packaging and Filling Machinery Businesses in China, Korea and T...
GlobeNewswire 1/4/2022 HERE launches Indoor Map as a service with SBB AG as first customer
GlobeNewswire 3/16/2018 GAM Holding AG: proposal of new member for the Board of Directors
GlobeNewswire 7/17/2017 Top Performers Build Six Elements into Organization Design
GlobeNewswire 11/10/2016 ISAPS Announces the Creation of a New Global Alliance to Address Patient Safety in Cosmetic Surgery,...
GlobeNewswire 10/20/2014 Nationale Suisse becomes part of the Helvetia Group
GlobeNewswire 9/22/2014 Helvetia Holding AG declares its public tender offer for Nationale Suisse to be successful
GlobeNewswire 5/23/2011 Annual Results / Annual General Meeting on June 14, 2011 in Zug
GlobeNewswire 7/16/2009 Jelmoli was informed of the intensions of major shareholders in connection with the exchange offer o...
GlobeNewswire 5/20/2009 Annual General Meeting of June 16, 2009: Board membership changes
GlobeNewswire 9/2/2008 Siemens and Bombardier to Deliver 121 Double-deck Intermediate Coaches to Swiss Federal Railways (SB...
GlobeNewswire 11/12/2007 Disclosure of shareholdings in accordance with Art. 20 SESTA
GlobeNewswire 4/12/2007 Swiss Life successfully places EUR 700 million of hybrid capital
GlobeNewswire 3/23/2005 According to the figures of the 2004 group management report: Funkwerk clearly exceeds growth target...
GlobeNewswire 11/18/2004 Hugin Ad hoc announcement according to § 15 WpHG: Contract: Funkwerk AG: Funkwerk wins contract from...
GlobeNewswire 11/18/2004 Funkwerk wins contract from Schweizerische Bundesbahnen
GlobeNewswire 7/24/2003 Swissmedic grants approval for the antihypertensive Diovan® to be used in the treatment of heart fai...